Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry. An in-depth look into the interaction between intellectual property rights
It has taken a long time for India to develop a productive environment for biotechnology, but Archana Shanker says recent developments appear to have put it on the right
It is not always easy to gain ownership of valuable IP assets through one’s own inventiveness. Instead, one way of remaining profitable and competitive is by licensing IP
Pravin Anand and Abhilasha Nautiyal look at how Indian common law is allowing rights-holders to amend their patent claims. A complete specification under the Patents Act, 1970 includes
Archana Shanker and Nupur Maithani consider what the battle over the Valcyte patent reveals about the Indian judiciary’s approach to pharmaceutical patents. The Valcyte patent has followed a
Interest in the repealed exclusive marketing rights provisions has been revived by a Supreme Court ruling clarifying the effect of the repeal cases on pending and decided applications.
